EMIL (Epigenetic Marker Ipomethylated for Acute Promyelocytic Leukemia) originates from the economic and scientific valorization of patent EP3458607, which concerns the use of an epigenetic signature for prognostic and/or diagnostic applications in the early assessment of Acute Promyelocytic Leukemia (APL). … Read More
Hypoxia-Regulated miRNAs in Human Mesenchymal Stem Cells: Exploring the Regulatory Effects in Ischemic Disorders
di Carmela Dell’Aversana — Permanent full researcher, at IEOS – CNR – ITALY — Human mesenchymal/stromal stem cells (hMSC) are the most promising cell source for adult cell therapies in regenerative medicine. Many clinical trials have reported the use of … Read More